Global Bioenergies has been awarded a grant of 500,000 euros to complete construction of the Pomacle unit and launch sales to the cosmetics industry.
Global Bioenergies - which has developed an innovative process for converting plant resources into a family of compounds used in cosmetics - announced last spring the decision to build a production unit on the Pomacle site, near Reims. The first phase of work was launched in the summer of 2021, and will enable production to start as early as March 2022.
The second phase of work will enable the plant to reach full capacity, producing around 100 tonnes a year of isobutene, the derivatives of which will be targeted at the make-up market, the first market selected by the company because of its high prices.
The financial support of the Grand Est Region, via a grant of 500,000 euros as part of the Plan France Relance, covers half of the second phase of construction of this industrial facility, and strengthens the historic links between Global Bioenergies and the Grand Est region. It contributes to the dynamism of the local industrial fabric through investment in innovative production tools.
Marc Delcourt, General Manager, comments: "We would like to thank the Grand Est Region for its invaluable support. Our Last brand has pushed back the boundaries of naturalness in make-up, and the upcoming launch of this new industrial tool will enable us to respond to the quest for naturalness by the major players in cosmetics."
Samuel Dubruque, Administrative and Financial Director, adds: " At the same time, we're working on obtaining other, larger-scale public funding: beyond cosmetics, our technology can be used for numerous applications in materials and fuels. In particular, the decarbonization of air transport is one of France's 10 priority objectives: our process stands out radically from other technical options, and has the potential to be one of the most competitive in the world."
